EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis in Brazil

Gustavo Maximiano-Alves, Carolina Lavigne-Moreira, Marcus Vinicius Simões, Adilson Junior Pinto Galvão, Flavio Henrique Valicelli, Fernando Saraiva Coneglian, Elisa Vegezzi iD, Pedro Manoel Marques Garibaldi, Pedro José Tomaselli, Andrea Cortese, Wilson Marques

Journal of the Peripheral Nervous System · 2026-03 · 31 (1)

DOI: 10.1111/jns.70097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 07.01.2026. Verfasst von Gustavo Maximiano-Alves und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Prealbumin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transthyretin hereditary amyloidosis (ATTRv) clinical variability has been widely reported, not only across countries and variants but also among families and distinct regions within a single nation. One of the principal challenges in disease management is the accurate determination of age of onset (AOO), which is heterogeneous and has therapeutic implications given the availability of disease‐modifying treatments.

Methods

This study characterizes the genetic landscape and clinical onset spectrum of ATTRv in an admixed Brazilian cohort of 175 patients.

Results

Seven TTR pathogenic variants (p.Val50Met, p.Val142Ile, p.Ile127Val, p.Ile88Leu, p.Ala39Asp, p.Phe84Leu, p.Tyr98Phe) were identified. The most common was p.Val50Met (58.8%), followed by p.Val142Ile (29.7%) and p.Ile127Val (7.4%). Notably, 44% of V122I had a neurological onset. Close clinical monitoring of presymptomatic carriers reduced age at diagnosis by 10.5 years. The median AOO was 50 years, with V30M patients presenting earlier (38.5 years) than V122I (p.Val142Ile) (60y) and I107V (p.Ile127Val) (60 years). Familial cases showed a 20.5‐year earlier AOO than sporadic cases. In Brazil, late‐onset (> 50 years) V30M is more common than previously reported (37.5%); ethnicity can influence AOO within the same variant, and for the first time, we show a distinct geographic pattern: early‐onset V30M is more frequent in São Paulo/South, whereas late‐onset V30M predominates in the central region.

Interpretation

This study emphasizes the heterogeneity of ATTRv presentation in admixed populations and underscores the need for expanded screening and multicenter studies to refine genotype–phenotypic correlations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialPrealbuminHumansBrazilFemaleMaleMiddle AgedAge of OnsetAdultAgedMutationCohort Studies

Stichwörter der Autor:innen

age of onsetgenetic variabilityhereditary transthyretin amyloidosisperipheral neuropathypresymptomatic screening

Substanzen

PrealbuminTTR protein, human

Autor:innen und Institutionen

  • Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Cardiology Division, Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
  • Multidisciplinary Center for Amyloidosis/Neurocop-Irece, Salvador, Brazil.
  • IRCCS Mondino Foundation, Pavia, Italy.
  • Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

ORCID-Profile: Elisa Vegezzi

Zitieren

APA

Maximiano-Alves, G., Lavigne-Moreira, C., Simões, M. V., Galvão, A. J. P., Valicelli, F. H., Coneglian, F. S., Vegezzi, E., Garibaldi, P. M. M., Tomaselli, P. J., Cortese, A., & Marques, W. (2026). Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis in Brazil. Journal of the Peripheral Nervous System, 31(1). https://doi.org/10.1111/jns.70097

Vancouver

Maximiano-Alves G, Lavigne-Moreira C, Simões MV, Galvão AJP, Valicelli FH, Coneglian FS, et al. Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis in Brazil. Journal of the Peripheral Nervous System. 2026;31(1). doi:10.1111/jns.70097

BibTeX
@article{MaximianoAlves2026,
  author = {Maximiano-Alves, Gustavo and Lavigne-Moreira, Carolina and Simões, Marcus Vinicius and Galvão, Adilson Junior Pinto and Valicelli, Flavio Henrique and Coneglian, Fernando Saraiva and Vegezzi, Elisa and Garibaldi, Pedro Manoel Marques and Tomaselli, Pedro José and Cortese, Andrea and Marques, Wilson},
  title = {Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis in Brazil},
  journal = {Journal of the Peripheral Nervous System},
  year = {2026},
  volume = {31},
  number = {1},
  doi = {10.1111/jns.70097}
}
Kostenlos starten →